CLINICAL_TRIALS
trial_result
· 2024-09-27
Clinical Trial Update: Open-label Study of ASP2151 in Herpes Simplex Patients [Phase 3]
Summary
An open-label Phase 3 clinical trial evaluating ASP2151 in patients with herpes simplex has completed, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Maruho Co., Ltd. | Conditions: Herpes Simplex | Phase 3 | Status: COMPLETED | Results posted: 2024-09-27